Global Primary Care POC Diagnostics Market – Industry Trends and Forecast to 2031

Primary Care POC Diagnostics Market Analysis and Size

Point-of-care testing diagnostics have numerous advantages, allowing patients to be diagnosed in a variety of settings, including the doctor's office, an ambulance, the home, the field, or the hospital. The outcomes of care are timely and provide the patient with prompt treatment. Chronic diseases, such as diabetes, rheumatism, and cancer, are becoming more common around the world for a variety of reasons, including an increase in the geriatric population, sedentary lifestyles, unhealthy eating habits, and environmental factors. Chronic diseases, for example, kill more than 38 million people worldwide each year. Cardiovascular diseases cause the most chronic disease deaths each year, killing 17.5 million people, followed by cancer (8.2 million), respiratory diseases (4 million), and diabetes (1.5 million).                                

Data Bridge Market Research analyzes that the primary care POC diagnostics market, which was USD 17,306.51 million in 2023, is likely to reach USD 28,081.22 million by 2031 and is expected to undergo a CAGR of 6.20% during the forecast period. “Immunoassays” dominates the platform segment of the primary care POC diagnostics market due to rising demand globally. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Primary care point-of-care diagnostics are techniques used to make an early and accurate diagnosis of a disease. These techniques are highly sensitive, cost-effective, and yield results in a short period of time. These techniques are used in hospitals, clinics, ambulatory care, home healthcare, and research laboratories.            

Global Primary Care POC Diagnostics Market Dynamics

Drivers

• Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and infectious diseases, is a major driver for the market. POC diagnostics offer rapid and convenient testing at the primary care level, enabling early detection and timely management of chronic conditions, thereby driving market growth.

• Growing emphasis on preventive healthcare

There is a growing emphasis on preventive healthcare, encouraging regular health check-ups and early disease detection. POC diagnostics play a crucial role in facilitating on-the-spot testing, allowing healthcare providers to quickly assess a patient's health status and provide immediate interventions or recommendations for preventive measures. This emphasis on proactive healthcare is driving the demand for POC diagnostics globally.

• Technological advancements in POC testing devices

Continuous advancements in technology have led to the development of more sophisticated and user-friendly POC testing devices. Miniaturization, increased accuracy, and connectivity features contribute to the efficiency of POC diagnostics, making them more accessible and appealing to healthcare providers. The integration of technologies like biosensors and mobile health applications enhances the capabilities of POC devices, driving market growth.

• Rapid expansion of point-of-care testing facilities

The rapid expansion of point-of-care testing facilities, not only in traditional healthcare settings but also in non-traditional environments such as pharmacies, community clinics, and remote or underserved areas, is a significant driver for the market. This expansion improves patient access to diagnostic services, reduces turnaround times for test results, and enhances overall healthcare outcomes, contributing to the market's growth. 

Opportunities

• Expansion in emerging markets

There are significant opportunities for the market to expand in emerging markets. As these regions experience economic growth and increased healthcare awareness, there is a growing demand for accessible and cost-effective diagnostic solutions. Companies can capitalize on this by introducing POC diagnostics tailored to the specific needs and infrastructure of emerging healthcare systems.

• Integration of artificial intelligence (AI) and digital health solutions

The integration of artificial intelligence (AI) and data analytics presents a promising opportunity for enhancing the capabilities of POC diagnostics. AI algorithms can improve the accuracy and interpretation of test results, enabling more sophisticated diagnostic capabilities. In addition, the use of data analytics can provide valuable insights into disease trends, patient outcomes, and healthcare management, creating new opportunities for innovation in the POC diagnostics market. 

Restraints

• Regulatory challenges and compliance

Stringent regulatory requirements for the approval and commercialization of POC diagnostic devices can pose significant restraints on the global market. Meeting the diverse regulatory standards across different regions and ensuring compliance with quality and safety regulations can be time-consuming and resource-intensive, potentially delaying product launches and market entry.

• Limited sensitivity and specificity

Some POC diagnostic tests may face challenges related to limited sensitivity and specificity compared to laboratory-based tests. Achieving high accuracy in POC diagnostics can be complex, and certain tests may have a higher likelihood of false positives or false negatives. Ensuring the reliability of results is crucial for gaining the trust of healthcare professionals and patients, and addressing these limitations is essential for market acceptance.

Challenges

• Infrastructure and connectivity issues

Access to reliable infrastructure, including power sources and internet connectivity, can be a challenge in some primary care settings, particularly in remote or underserved areas. POC diagnostic devices often rely on connectivity for data transfer and remote monitoring. Overcoming infrastructure limitations and developing solutions that can function effectively in resource-limited environments are critical challenges for the global POC diagnostics market.

• Cost constraints

The cost associated with developing and manufacturing technologically advanced POC diagnostic devices can be a significant restraint. Healthcare facilities, especially in resource-limited settings, may face budget constraints that limit their ability to invest in expensive POC technologies. Achieving a balance between affordability and technological sophistication is crucial to ensuring widespread adoption and market penetration. 

This primary care POC diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the primary care POC diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2022, UK-based LumiraDx Healthcare launched its highly sensitive C-Reactive Protein (CRP) point of care (POC) antigen test across India. The point of care CRP test can be used in multiple clinical settings to help reduce unnecessary antibiotic prescribing that leads to antimicrobial resistance (AMR)
• In October 2022, Genes2Me Pvt. Ltd launched Rapi-Q- Point of Care RT PCR solution for human papillomavirus (HPV) and tuberculosis. The device is easy to use and gives faster results in less than 45 minutes. This CE-IVD-marked POC solution delivers superior performance, high sensitivity, and stable detection

Global Primary Care POC Diagnostics Market Scope

The primary care POC diagnostics market is segmented on the basis of platform, prescription, end-user, and product. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Platform

• Lateral flow assays
• Dipsticks
• Microfluidics
• Molecular diagnostics
• Immunoassays
• Others

Prescription

• Prescription Based
• OTC testing

End User

• Professional diagnostic centers
• Research laboratories
• Home care
• Others

Product

• Glucose
• Cardio metabolic
• Infectious disease
• Influenza
• HIV
• Hepatitis C
• Sexually transmitted disease (STD)
• Healthcare-associated infection (HAI)
• Respiratory infection
• Tropical disease
• Other infectious disease
• Coagulation, PT/INR activated clotting time (ACT/APTT)
• Pregnancy and fertility
• Tumor/cancer marker
• Urinalysis
• Cholesterol
• Hematology
• Drugs-of-abuse
• Fecal occult
• Other POC products

Global Primary Care POC Diagnostics Market Regional Analysis/Insights

The primary care POC diagnostics market is analyzed and market size insights and trends are provided by country, platform, prescription, end-user, and product as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Brazil, Argentina, rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and rest of Middle East and Africa.

North America is expected to dominate the market due to the sustenance on the constant research activities on the primary care POC diagnostics market.

Asia-Pacific is projected to observe significant amount of growth in the market due to the rise in the disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Primary Care POC Diagnostics Market Share Analysis

The primary care POC diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to primary care POC diagnostics market.

Some of the major players operating in the primary care POC diagnostics market are:

• Abbott (U.S.)
• Siemens Healthineers AG (Germany)
• Quidel Corporation (U.S.)
• F. Hoffman-La Roche Ltd. (Switzerland)
• Danaher Corporation (U.S.)
• Becton, Dickinson and Company (U.S.)
• Chembio Diagnostics (U.S.)
• EKF Diagnostics (U.K.)
• Trinity Biotech plc (Ireland)
• Instrumentation Laboratory (a Werfen Company) (U.S.)
• Nova Biomedical (U.S.)
• PTS Diagnostics (U.S.)
• Sekisui Diagnostics (U.S.)
• Thermo Fisher Scientific (U.S.)
• bioMérieux S.A. (France)

SKU-70393